Metoprolol Succinate Tablet, Extended Release
Product Images NDC 70436-166

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 70436-166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure diagram of metoprolol succinate, showing the molecular components and arrangement for the active ingredient metoprolol succinate in the drug product.*

FDA Label Image

Picture-1 (Picture 1)

A forest plot chart titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals for three outcomes: Total Mortality, Total Mortality or All-Cause Hospitalization (Time to First Event), and Total Mortality or Hospitalization for Heart Failure (Time to First Event). The plot compares metoprolol succinate extended-release tablets versus placebo across various patient subgroups including geographic region, NYHA class, ejection fraction, etiology, sex, race, previous myocardial infarction, diabetes, hypertension, and heart rate.*

FDA Label Image

25mg-100ct-slaterun (25mg 100ct Slaterun)

Label for Metoprolol Succinate Extended-Release Tablets, USP 25 mg by Slate Run Pharmaceuticals. It includes storage information, dosage caution, child-resistant packaging note, manufacturer details (Yichang Humanwell Oral Solid Dosage Plant, China), distributor information, barcode, and a refill instruction. The package contains 100 tablets.*

FDA Label Image

25mg-500ct-slaterun (25mg 500ct Slaterun)

Metoprolol succinate extended-release tablets, USP, 25 mg strength, oral dosage form. The label shows this is a 500 tablet package by Slate Run Pharmaceuticals, LLC. It includes storage instructions, manufacturer information, and a barcode. The label specifies that each tablet contains 23.75 mg metoprolol succinate equivalent to 25 mg metoprolol tartrate, USP.*

FDA Label Image

25mg-1000ct-slaterun (25mg 1000ct Slaterun)

Metoprolol Succinate Extended-Release Tablets, USP 25 mg, oral tablets by Slate Run Pharmaceuticals. The label states the package contains 1,000 tablets. It includes dosage information, warnings, storage conditions, manufacturing and distribution details, and a barcode. The label is white with blue and yellow accents.*

FDA Label Image

50mg-100ct-slaterun (50mg 100ct Slaterun)

Label for Metoprolol Succinate Extended-Release Tablets USP, 50 mg strength, manufactured by Yichang Humanwell and distributed by Slate Run Pharmaceuticals, LLC. The label indicates a package of 100 tablets with storage instructions and a barcode. The label also notes child-resistant packaging and dosage information referencing a package insert.*

FDA Label Image

50mg-500ct-slaterun (50mg 500ct Slaterun)

Label for Metoprolol Succinate Extended-Release Tablets USP, 50 mg strength, in a bottle containing 500 tablets. The label states the drug is distributed by Slate Run Pharmaceuticals, LLC, with manufacturing by Yichang Humanwell Oral Solid Dosage Plant, China. Storage instructions, dosage warnings, and child-resistant packaging information are also included.*

FDA Label Image

50mg-1000ct-slaterun (50mg 1000ct Slaterun)

Label for Metoprolol Succinate Extended-Release Tablets, USP 50 mg by Slate Run Pharmaceuticals. The label indicates 1,000 tablets in the container with storage instructions and a warning to keep out of reach of children. It includes manufacturer and distributor details and a barcode, with a coating free area for expiration, lot, and serialization data.*

FDA Label Image

100mg-100ct-slaterun (100mg 100ct Slaterun)

Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, extended-release oral tablets from Slate Run Pharmaceuticals. The label shows the NDC number 70436-166-01 and specifies a package count of 100 tablets. It includes storage instructions, a child-resistance notice, manufacturer details in China, and distributor information in Columbus, Ohio.*

FDA Label Image

100mg-500ct-slaterun (100mg 500ct Slaterun)

Metoprolol succinate extended-release tablets, USP, 100 mg strength, oral dosage form. The label indicates 500 tablets per package. Manufactured by Yichang Humanwell Oral Solid Dosage Plant, China, and distributed by Slate Run Pharmaceuticals, LLC. Includes storage instructions, warning, dosage note, and barcode. Also mentions coating free area for expiration, lot, and serialization data.*

FDA Label Image

100mg-1000ct-slaterun (100mg 1000ct Slaterun)

Label for Metoprolol Succinate Extended-Release Tablets, USP 100 mg, by Slate Run Pharmaceuticals. The label states the quantity as 1,000 tablets. It includes storage instructions, a warning to keep out of children's reach, and manufacturing details for Yichang Humanwell Oral Solid Dosage Plant in China.*

FDA Label Image

200mg-100ct-slaterun (200mg 100ct Slaterun)

Packaging label for Metoprolol Succinate Extended-Release Tablets, USP 200 mg by Slate Run Pharmaceuticals, LLC. The label states the 200 mg strength corresponds to 190 mg metoprolol succinate equivalent to 200 mg metoprolol tartrate. The package contains 100 tablets and includes storage instructions, a warning to keep out of reach of children, and manufacturing details indicating production at Yichang Humanwell Oral Solid Dosage Plant, China.*

FDA Label Image

200mg-500ct-slaterun (200mg 500ct Slaterun)

Label for Metoprolol Succinate Extended-Release Tablets, USP, 200 mg strength, oral dosage form, manufactured by Yichang Humanwell Oral Solid Dosage Plant and distributed by Slate Run Pharmaceuticals, LLC. Package contains 500 tablets. Storage and dispensing instructions and barcode are visible.*

FDA Label Image

200mg-1000ct-slaterun (200mg 1000ct Slaterun)

Label for Metoprolol Succinate Extended-Release Tablets, USP, 200 mg, oral tablet. The label indicates prescription use only and a quantity of 1,000 tablets. It includes storage instructions and manufacturer details: made by Yichang Humanwell Oral Solid Dosage Plant, China, distributed by Slate Run Pharmaceuticals, LLC, Columbus, OH.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.